IROC yields 5.07% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 2
Combined, IROC + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IROC + MRK for your $10,000?
Invesco Rochester High Yield Municipal ETF (fund) is an actively managed exchange-traded fund (ETF) that seeks current income exempt from federal income tax. The fund seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its net assets in higher yielding municipal securities, specifically medium-and-lower grade municipal securities. The fund will normally maintain a weighted average portfolio duration of less than 7.5 years.Effective February 24, 2025, The Fund will invest at least 75% of its total assets in low-to medium-quality municipal securities. The Fund’s name will change to “Invesco Rochester High Yield Municipal ETF.” As a result of this change, the Fund will also change its ticker to “IROC.”Effective July 1, 2025 through June 30, 2026, Invesco Capital Management LLC (the “Adviser”) will voluntarily waive 100% of its management fee, 0.39%, for the Fund. The Net Expense Ratio for the Fund through June 30, 2026 is 0.00%.
Full IROC Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.